e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
To study pulmonary hemodynamics and the prevalence of porto pulmonary hypertension (POPH) in cirrhotic patients
S. Kumar, P.K. Sharma, M.K. Sharma, A. Kumar, S.K. Sarin (New Delhi, India)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session:
Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session type:
Poster Discussion
Number:
1511
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kumar, P.K. Sharma, M.K. Sharma, A. Kumar, S.K. Sarin (New Delhi, India). To study pulmonary hemodynamics and the prevalence of porto pulmonary hypertension (POPH) in cirrhotic patients. Eur Respir J 2012; 40: Suppl. 56, 1511
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Respiratory sequelae of preterm birth across the life span
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 770
Year: 2009
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Bedside prediction of pulmonary hypertension among cirrhotic patients with portal hypertension
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
The prevalence of pulmonary hypertension in cirrhotic patients submitted to hepatic transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 465s
Year: 2003
Prevalence of pulmonary arterial hypertension in idiopathic pulmonary fibrosis: a multicenter study
Source: Eur Respir J 2007; 30: Suppl. 51, 119s
Year: 2007
Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 364s
Year: 2006
Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Characteristics and outcome of patients with pre-capillary pulmonary hypertension who were drained for tamponade: A monocentric study
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
Capillaroscopic findings in patients with pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept